Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Willow Biosciences Inc T.WLLW

Alternate Symbol(s):  CANSF

Willow Biosciences Inc. is a Canada-based biotechnology company. The Company develops and produces precision fermented functional ingredients for the health and wellness, food and beverage and personal care markets. Its FutureGrown biotechnology platform allows production with sustainability at its core. Its commercial product, Cannabigerol CBG, which is a cannabinoid that has anti-microbial, anti-inflammatory, and antioxidant properties. It also offers BioOxi, a bio-oxidation technology platform. By leveraging BioOxi, commercial partners can revolutionize manufacturing of oxygenated and hydroxylated functional ingredients, such as steroids, polyphenols, oxyterpenes and certain other targeted ingredients produced from such methods. It is also developing BioOxi-based process for production of the generic active pharmaceutical ingredient (API), hydrocortisone, and its derivatives. Its other pipeline products include Ursodeoxycholic acid (UCAC), Astaxanthin, B-carotene and others.


TSX:WLLW - Post by User

Bullboard Posts
Comment by jethro549on Nov 20, 2016 2:39pm
140 Views
Post# 25486857

RE:RE:RE:RE:AGM..DEC 22/16.. #7-CONSOLIUDATION AUTHORIZATION

RE:RE:RE:RE:AGM..DEC 22/16.. #7-CONSOLIUDATION AUTHORIZATION Take Redstar Gold as an example. 356 Million shares out, one workable property, until recently no cash and they have a 33 Million dollar market cap. Companies can operate with one very solid property especially in a highly regarded area like the Golden Triangle. Good results at Clone will make Mkena a player again. Forget share roll backs, if you don't want it just vote against it. Exercise your right as a shareholder. The problem is nobody every votes. Clone is a great property with great past bulk samples which puts them at the advanced exploration stage. The next phase will bring us closer to an economic assessment. Cash raising will be much easier with great results in the bank and the amount of shares sold will be much less with the share price at .08 or higher. Hang tight. 
Bullboard Posts